FDA approves hepatitis C drug
BY Advocate.com Editors
October 15 2003 12:00 AM ET
The Food and Drug Administration on Monday approved Schering-Plough's prefilled pen-like syringe that contains the company's PEG-Intron hepatitis C treatment. The device, called the PEG-Intron Redipen, was designed to be easier to use than traditional syringes and vials of the medication. It is expected to be available in the United States in early 2004. PEG-Intron Redipen is already sold in Europe. Hepatitis C is a common coinfection among HIV-positive people and is one of the leading killers of people who are infected with HIV. Hepatitis C is commonly transmitted through contact with infected blood, but studies have shown it may also be transmitted through sexual contact.
- Indiana Newspaper Sends Big Message
- Op-ed: Angelina Jolie's Choice Bolsters the Trans Argument
- Subaru Comes Out Against Indiana's 'License to Discriminate'
- Mormon Missionary Positions
- Alan Cumming Is Bisexual — And You Might Be Too
- Op-ed: 'Religious Discrimination' Laws Have Nothing to Do With Religion